← FDA Drug Approvals (Drugs@FDA)
MYHIBBIN
NDA · New Drug Application · Sponsor: AZURITY · Approved 2024-05-01
Drug application
- FDA Application #
NDA216482- Application type
- New Drug Application
- Brand name
- MYHIBBIN
- Generic name
- MYCOPHENOLATE MOFETIL
- Active ingredients
- MYCOPHENOLATE MOFETIL
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AZURITY
- Manufacturer
- Azurity Pharmaceuticals, Inc.
- First approval
- 2024-05-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown